Innovating Protease Inhibition: Advancing Targeted Therapies for Disease Treatment
Protease inhibition faces challenges due to specificity and safety concerns. Innovative approaches, including non-natural peptide inhibitors (NNPIs) and antibody-conjugated delivery (APICs), show promise in targeting cancers and diseases, enabling precise, effective, and safer treatments through tai...